From: Significance of peak oxygen pulse in patients with chronic obstructive pulmonary disease
 | Total (n = 50) | Group I (n = 16) | Group II (n = 34) | Test of Sig | p |
---|---|---|---|---|---|
Sex | |||||
 Male | 49 (98%) | 16 (100%) | 33 (97%) | χ2 = 0.480 | FEp = 1.000 |
 Female | 1 (2%) | 0 (0%) | 1 (3%) | ||
Age (/years) | |||||
 Mean ± SD | 57.0 ± 9.10 | 54.63 ± 8.61 | 58.12 ± 9.24 | t = 1.274 | 0.209 |
 Median (Min. – Max.) | 59.50(31.0 – 75.0) | 54.0(43.0 – 75.0) | 60.0(31.0 – 74.0) | ||
BH (cm) | |||||
 Mean ± SD | 168.0 ± 6.32 | 168.4 ± 7.96 | 167.8 ± 5.52 | t = 0.348 | 0.729 |
 Median (Min. – Max.) | 169.5(152.0–183.0) | 170.5(152.0–183.0) | 167.0(155.0–180.0) | ||
BW (kg) | |||||
 Mean ± SD | 75.42 ± 15.18 | 86.50 ± 14.39 | 70.21 ± 12.68 | t = 4.060* |  < 0.001* |
 Median (Min. – Max.) | 74.0(50.0 – 115.0) | 85.0(60.0 – 115.0) | 68.50(50.0 – 100.0) | ||
BMI (kg/m2) | |||||
 Mean ± SD | 26.92 ± 5.33 | 30.53 ± 5.17 | 25.22 ± 4.55 | t = 3.902* |  < 0.001* |
 Median (Min. – Max.) | 25.85(16.5 – 38.95) | 30.20(24.3 – 38.95) | 24.65(16.5 – 38.29) | ||
Hemoglobin | |||||
 Mean ± SD | 12.67 ± 1.27 | 12.78 ± 1.18 | 12.63 ± 1.32 | t = 0.383 | 0.703 |
 Median (Min. – Max.) | 12.50(10.50–15.20) | 12.65(11.0–15.10) | 12.50(10.50–15.20) | ||
Gold | |||||
 I | 7 (14%) | 5 (31%) | 2 (6%) | χ2 = 9.906* | MCp = 0.014* |
 II | 11 (22%) | 4 (25%) | 7 (21%) | ||
 III | 22 (44%) | 7 (44%) | 15 (44%) | ||
 IV | 10 (20%) | 0 (0%) | 10 (29%) | ||
ABCD assessment | |||||
 A | 2 (4%) | 2 (13%) | 0 (0%) | χ2 = 19.845* | MCp < 0.001* |
 B | 12 (24%) | 9 (56%) | 3 (9%) | ||
 C | 18 (36%) | 4 (25%) | 14 (41%) | ||
 D | 18 (36%) | 1 (6%) | 17 (50%) | ||
Smoking | |||||
 Current smoker | 36 (72%) | 12 (75%) | 24 (71%) | χ2 = 0.105 | FEp =  1.000 |
 Ex–smoker | 14 (28%) | 4 (25%) | 10 (29%) |